(Q43978616)

28 November 2017

Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study (English)

1 reference

28 November 2017

1 reference

5

Moyses Szklo

1 reference

28 November 2017

7

Gerardo Heiss

1 reference

28 November 2017

Pamela J Schreiner

1

1 reference

28 November 2017

Kenneth K Wu

2

1 reference

28 November 2017

M Rene Malinow

3

1 reference

28 November 2017

Valarie L Stinson

4

1 reference

28 November 2017

F Javier Nieto

6

1 reference

28 November 2017

1 May 2002

1 reference

28 November 2017

Annals of Epidemiology

1 reference

28 November 2017

12

1 reference

28 November 2017

4

1 reference

28 November 2017

228-236

1 reference

Hyperhomocysteinemia: an independent risk factor for vascular disease

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocysteinemia due to folate deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Serum total homocysteine and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Plasma homocyst(e)ine levels in men with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocysteine and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

The pathogenesis of coronary artery disease. A possible role for methionine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Prospective studies of homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Endothelial cell damage and homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Endothelium-Derived Relaxing Factor Modulates the Atherothrombogenic Effects of Homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

Homocysteine and vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900311-8

7 January 2021

10.1016/S1047-2797(01)00311-8

Identifiers

DOI

1 reference

28 November 2017

1 reference